Trade BLSM stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
BlossomHill Therapeutics, Inc. (BLSM) is trading at US$16.88, up 1.63% today as of Oct 8, 16:00 EDT. The company has a market capitalisation of US$476.35M. Over the past 52 weeks, BLSM has traded between US$15.25 and US$27.99. On Syfe you can trade BLSM with $0 commission and add it to your watchlist.
| Previous close | US$16.61 |
|---|---|
| Market cap | US$476.35M |
| 52-week range | US$15.25 – US$27.99 |
| Volume | 165.15K |
| Exchange | US |
BlossomHill Therapeutics, Inc.
Blossomhill Therapeutics, Inc. is a clinical-stage biopharmaceutical company. It engages in the development of small molecule medicines for unmet medical needs in cancer treatment. The company was founded on June 22, 2020 and is headquartered in San Diego, CA.
Year: 2026
--Leerink Partners Initiates BlossomHill Therapeutics at Outperform, $36 Price Target
Sep 1, 11:24 AM · MT Newswires
--JPMorgan Initiates BlossomHill Therapeutics at Overweight
Sep 1, 11:08 AM · MT Newswires
BlossomHill Therapeutics, Inc. (BLSM) stock is trading at US$16.88, +1.63% from the previous close of US$16.61.
The market cap for BlossomHill Therapeutics, Inc. (BLSM) stock is approximately US$476.35M.
The 52-week high for BlossomHill Therapeutics, Inc. (BLSM) stock is US$27.99.
The 52-week low for BlossomHill Therapeutics, Inc. (BLSM) stock is US$15.25.
BlossomHill Therapeutics, Inc. (BLSM) does not currently pay a dividend.
Stay on top of BLSM
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
Popular Stocks in Singapore
